NASDAQ
Checkpoint Therapeutics, Inc. (CKPT) has a price/sales ratio of 3096.54x as of Friday, May 22, 2026. This represents a 640.55% increase compared to its 12-month average of 418.14x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.